The expansion began several years ago when it launched its first successful drug, Eylea, which treats age-related macular degeneration, a common …



Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *